VOLUME 10 (2019)
View Archive »
About The Cover
The cover for issue 10 of Oncotarget features Figure 6, "Model of the role of LATS1/2 kinases in the pre–self-renewal (pre-SR) stage during sphere formation by CSCs," by Nozaki, et al.
|
|
Table of Contents
Priority Research Papers
|
| LATS1/2 kinases trigger selfrenewal of cancer stem cells in aggressive oral cancer |
|
https://doi.org/10.18632/oncotarget.26583
|
| 1014-1030 |
Research Papers
|
| Therapeutic potential of nimotuzumab PEGylatedmaytansine antibody drug conjugates against EGFR positive xenograft |
|
https://doi.org/10.18632/oncotarget.26613
|
| 1031-1044 |
|
| Glypican1 and glycoprotein 2 bearing extracellular vesicles do not discern pancreatic cancer from benign pancreatic diseases |
|
https://doi.org/10.18632/oncotarget.26620
|
| 1045-1055 |
|
| Src kinase inhibition restores Ecadherin expression in dasatinibsensitive pancreatic cancer cells |
|
https://doi.org/10.18632/oncotarget.26621
|
| 1056-1069 |
|
| Safety and effectiveness of FOLFOXIRI plus molecular target drug therapy for metastatic colorectal cancer: A multicenter retrospective study |
|
https://doi.org/10.18632/oncotarget.26626
|
| 1070-1084 |
|
| Andrographolide induces DNA damage in prostate cancer cells |
|
https://doi.org/10.18632/oncotarget.26628
|
| 1085-1101 |
|
| Oxalate induces type II epithelial to mesenchymal transition EMT in inner medullary collecting duct cells IMCD in vitro and stimulate the expression of osteogenic and fibrotic markers in kidney medulla in vivo |
|
https://doi.org/10.18632/oncotarget.26634
|
| 1102-1118 |
|
| The correlation of p22phox and chemosensitivity in EGFRTKI resistant lung adenocarcinoma |
|
https://doi.org/10.18632/oncotarget.26637
|
| 1119-1131 |
|
| Repurposing old carbon monoxidereleasing molecules towards the antiangiogenic therapy of triplenegative breast cancer |
|
https://doi.org/10.18632/oncotarget.26638
|
| 1132-1148 |
|
| Reliable evaluation of tumorinfiltrating lymphocytes in pancreatic cancer tissue biopsies |
|
https://doi.org/10.18632/oncotarget.26646
|
| 1149-1159 |
|
| Nterminal probrain natriuretic peptide reflects both left ventricular diastolic dysfunction and myelomarelated renal insufficiency and robustly predicts mortality in patients with symptomatic multiple myeloma |
|
https://doi.org/10.18632/oncotarget.26647
|
| 1160-1170 |
Copyright © 2026 Rapamycin Press LLC dba Impact Journals
Oncotarget ® is a registered trademark of Rapamycin Press LLC
Impact Journals ® is a registered trademark of Rapamycin Press LLC
RAPAMYCIN PRESS ® is a registered trademark of Rapamycin Press LLC
